Mark Nixon

1.1k total citations
42 papers, 741 citations indexed

About

Mark Nixon is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Mark Nixon has authored 42 papers receiving a total of 741 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 9 papers in Physiology. Recurrent topics in Mark Nixon's work include Hormonal Regulation and Hypertension (17 papers), Adrenal Hormones and Disorders (13 papers) and Stress Responses and Cortisol (6 papers). Mark Nixon is often cited by papers focused on Hormonal Regulation and Hypertension (17 papers), Adrenal Hormones and Disorders (13 papers) and Stress Responses and Cortisol (6 papers). Mark Nixon collaborates with scholars based in United Kingdom, United States and Netherlands. Mark Nixon's co-authors include Ruth Andrew, Brian R. Walker, Roland H. Stimson, Karen E. Chapman, Patrick W. F. Hadoke, Edwin J.R. van Beek, Lynne Ramage, Murat Akyol, John Forsythe and Nicholas M. Morton and has published in prestigious journals such as Nature Communications, Immunity and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mark Nixon

38 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Nixon United Kingdom 14 231 187 141 120 89 42 741
Maha M. Hammad Kuwait 14 148 0.6× 85 0.5× 226 1.6× 104 0.9× 26 0.3× 32 604
M Brönnegård Sweden 19 361 1.6× 359 1.9× 203 1.4× 143 1.2× 60 0.7× 26 1.1k
Steven Timmermans Belgium 11 89 0.4× 135 0.7× 269 1.9× 84 0.7× 71 0.8× 30 744
Jacobie Steenbergen Netherlands 19 281 1.2× 267 1.4× 246 1.7× 110 0.9× 35 0.4× 31 927
Jolien Souffriau Belgium 8 126 0.5× 120 0.6× 188 1.3× 63 0.5× 67 0.8× 9 658
Verena Briner Switzerland 16 204 0.9× 200 1.1× 427 3.0× 68 0.6× 42 0.5× 38 1.2k
M. Ángeles Martínez‐García Spain 21 281 1.2× 196 1.0× 538 3.8× 153 1.3× 45 0.5× 56 1.4k
Anna Borkowska Poland 14 123 0.5× 75 0.4× 208 1.5× 124 1.0× 19 0.2× 60 710
Erini Dermitzaki Greece 10 125 0.5× 149 0.8× 101 0.7× 165 1.4× 230 2.6× 10 620
Alison Davies United Kingdom 10 251 1.1× 207 1.1× 310 2.2× 116 1.0× 23 0.3× 18 870

Countries citing papers authored by Mark Nixon

Since Specialization
Citations

This map shows the geographic impact of Mark Nixon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Nixon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Nixon more than expected).

Fields of papers citing papers by Mark Nixon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Nixon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Nixon. The network helps show where Mark Nixon may publish in the future.

Co-authorship network of co-authors of Mark Nixon

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Nixon. A scholar is included among the top collaborators of Mark Nixon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Nixon. Mark Nixon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villalobos, Elisa, Natalie Homer, Ruth Andrew, et al.. (2025). The NE/AAT/CBG axis regulates adipose tissue glucocorticoid exposure. Nature Communications. 16(1). 545–545. 4 indexed citations
2.
Lachmann, Robin, Elaine Murphy, Gavin Clunie, et al.. (2025). Real-World Effectiveness of Burosumab in Adults with X-Linked Hypophosphataemia (XLH) in the UK. Calcified Tissue International. 116(1). 122–122.
3.
Salek, Sam, Faraz M Ali, Kennedy Otwombe, et al.. (2025). Multiple sclerosis greatly impacts family members/partners: Evidence using the Family Reported Outcome Measure (FROM-16). Multiple Sclerosis Journal - Experimental Translational and Clinical. 11(2). 3120701962–3120701962.
4.
Hadoke, Patrick W. F., et al.. (2025). Obesity-induced mesenteric PVAT remodelling is sexually dimorphic, but not driven by ovarian hormones. Cardiovascular Diabetology. 24(1). 39–39. 3 indexed citations
5.
Finlay, A.Y., Faraz M Ali, Harris Allen, et al.. (2024). Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: A cross‐sectional study. European Journal Of Haematology. 113(1). 117–126. 4 indexed citations
6.
Villalobos, Elisa, Ruth Morgan, Joanna Simpson, et al.. (2024). ATP-binding cassette family C member 1 constrains metabolic responses to high-fat diet in male mice. Journal of Endocrinology. 262(2). 1 indexed citations
7.
Finlay, A.Y., Sam Salek, Harris Allen, et al.. (2024). Responsiveness and minimal important change of the Family Reported Outcome Measure (FROM-16). Journal of Patient-Reported Outcomes. 8(1). 38–38. 7 indexed citations
8.
Nixon, Mark, et al.. (2024). ACBP orchestrates the metabolic phenotype in Cushing’s syndrome. Nature Metabolism. 6(12). 2220–2221.
9.
Morgan, Ruth, et al.. (2023). Perivascular adipose tissue: a driver of sex-specific differences in the vascular outcomes of obesity. Physiology. 38(S1). 1 indexed citations
10.
Kamenický, Peter, Karine Briot, Maria Luisa Brandi, et al.. (2023). Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment. RMD Open. 9(1). e002676–e002676. 20 indexed citations
11.
Costello, Hannah M., David Severs, Alicja Czopek, et al.. (2022). High salt intake activates the hypothalamic–pituitary–adrenal axis, amplifies the stress response, and alters tissue glucocorticoid exposure in mice. Cardiovascular Research. 119(8). 1740–1750. 13 indexed citations
12.
Villalobos, Elisa, Ruth Andrew, Rebecca M. Reynolds, et al.. (2022). The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action. Nature Reviews Endocrinology. 19(2). 112–124. 20 indexed citations
13.
Villalobos, Elisa, Mark Nixon, Lee Murphy, et al.. (2021). Carbonyl reductase 1 amplifies glucocorticoid action in adipose tissue and impairs glucose tolerance in lean mice. Molecular Metabolism. 48. 101225–101225. 6 indexed citations
14.
Jackson‐Jones, Lucy H., Peter Smith, Jordan R. Portman, et al.. (2020). Stromal Cells Covering Omental Fat-Associated Lymphoid Clusters Trigger Formation of Neutrophil Aggregates to Capture Peritoneal Contaminants. Immunity. 52(4). 700–715.e6. 62 indexed citations
15.
Nixon, Mark, Natalie Homer, Dawn E. W. Livingstone, et al.. (2016). ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: A rationale for safer glucocorticoid replacement therapy. Science Translational Medicine. 8(352). 352ra109–352ra109. 40 indexed citations
16.
Ramage, Lynne, Murat Akyol, Alison Fletcher, et al.. (2016). Glucocorticoids Acutely Increase Brown Adipose Tissue Activity in Humans, Revealing Species-Specific Differences in UCP-1 Regulation. Cell Metabolism. 24(1). 130–141. 153 indexed citations
17.
Nixon, Mark, Jingqi Fu, Dmitry Akhmedov, et al.. (2015). Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity. Molecular Metabolism. 5(1). 34–46. 46 indexed citations
18.
Nixon, Mark, Ruth Andrew, & Karen E. Chapman. (2012). It takes two to tango: Dimerisation of glucocorticoid receptor and its anti-inflammatory functions. Steroids. 78(1). 59–68. 49 indexed citations
19.
Nixon, Mark, et al.. (2011). 5α-Reduced glucocorticoids: a story of natural selection. Journal of Endocrinology. 212(2). 111–127. 41 indexed citations
20.
Nixon, Mark, et al.. (1965). TREATMENT OF INFECTIONS WITH COLISTIMETHATE SODIUM (COLY-MYCIN).. PubMed. 93. 143–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maha M. Hammad Breakdown of academic impact, for papers by M Brönnegård Breakdown of academic impact, for papers by Steven Timmermans Breakdown of academic impact, for papers by Jacobie Steenbergen Breakdown of academic impact, for papers by Jolien Souffriau Breakdown of academic impact, for papers by Verena Briner Breakdown of academic impact, for papers by M. Ángeles Martínez‐García Breakdown of academic impact, for papers by Anna Borkowska Breakdown of academic impact, for papers by Erini Dermitzaki Breakdown of academic impact, for papers by Alison Davies
Rankless by CCL
2026